Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin
Launched by INTEGRATIVE SKIN SCIENCE AND RESEARCH · Jul 4, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new skin balancing gel cream to see if it is safe and how it affects the skin's natural bacteria in people who have mild to moderate acne that is not cystic. Researchers want to understand if this cream can help improve skin health while keeping the skin's microbiome, which is important for skin balance, healthy.
To participate, individuals must be between 18 and 35 years old and have mild to moderate acne. Both men and women can join, but men will need to shave their facial hair. Participants will need to stop using certain acne treatments for two weeks before starting the study. Throughout the trial, participants will use the gel cream provided by the researchers and will be asked to avoid other facial products, except for a gentle cleanser. It's important to note that pregnant or breastfeeding individuals and those with severe acne cannot join this study. If you are interested in improving your acne and meeting the eligibility criteria, this trial may be a good opportunity for you!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and females between the ages of 18 years of age until 35 years of age
- • Males must be willing to shave facial hair
- • The presence of mild to moderate non-cystic acne based on investigator global assessment
- Exclusion Criteria:
- • Individuals who are pregnant or breastfeeding.
- • Prisoners.
- • Adults unable to consent.
- • The presence of severe acne or cysts as noted by the investigator.
- • Those who are unwilling to discontinue topical antibiotics, topical salicylic acid containing products and topical benzoyl peroxide containing products for two weeks to meet the washout criteria prior to enrolling.
- • Those who are unwilling to discontinue all facial topical products except the cleanser and the product provided in the study.
- • Individuals who have been on an oral antibiotic for acne within the previous 1 month.
- • Individuals who have changed any of their hormonal based contraception within 3. months prior to joining the study.
- • Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years.
About Integrative Skin Science And Research
Integrative Skin Science and Research is a leading clinical trial sponsor dedicated to advancing dermatological science through innovative research and development. With a focus on integrative approaches that combine traditional and contemporary methodologies, the organization conducts rigorous clinical trials aimed at evaluating the safety and efficacy of novel skin therapies. Committed to enhancing patient care, their multidisciplinary team collaborates with healthcare professionals and researchers to ensure the highest standards of scientific integrity and ethical practices in all studies. By fostering partnerships with academic institutions and industry leaders, Integrative Skin Science and Research strives to contribute significantly to the field of dermatology and improve outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Raja Sivamani, MD MS AP
Principal Investigator
Integrative Skin Science and Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported